Research
Hormonal
Semaglutide differs from other GLP-1 receptor agonists by having a longer half-life and producing greater weight loss.
Semaglutide may offer advantages over other GLP-1 agonists for weight loss due to its pharmacokinetic profile.
StrongSupportsmedium confidence
Semaglutide differs from other GLP-1 receptor agonists by having a longer half-life and producing greater weight loss.
Why this rating
The statement is based on comparative analysis within the abstract.
Source
Semaglutide for Weight Loss: Was It Worth the Weight?
Joel Novograd et al. · Cardiology in Review · 2022
reviewCited 14×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →